DesJardin Michael A.'s Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Apr 14, 2022
- Accession no.
- 0001209191-22-024440
- Filed
- Apr 14, 2022
- Trade date
- Apr 12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.29M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DesJardin Michael A.CIK 0001512985 | Officer (EVP, Technical Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2022 | Ordinary Shares | SSaleDisposed | −9,150 | $112.55 | −$1,029,832.5 | 93,410 | Direct | |
| Apr 12, 2022 | Ordinary Shares | SSaleDisposed | −11,064 | $113.60 | −$1,256,870.4 | 82,346 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.